NCT03078712View on ClinicalTrials.gov

Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK Study

NACompletedINTERVENTIONAL
Enrollment

424

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

March 15, 2018

Study Completion Date

June 30, 2018

Conditions
Septic ShockHyperlactatemiaPeripheral Perfusion
Interventions
OTHER

Peripheral Perfusion guided resuscitation

Sequential approach with fluids (guided by dynamic predictors of fluid responsiveness), vasopressors titration, and inodilators according to peripheral perfusion.

OTHER

Lactate guided resuscitation

Sequential approach with fluids (guided by dynamic predictors of fluid responsiveness), vasopressors titration, and inodilators according to lactate decrease.

Trial Locations (1)

7500000

Pontificia Universidad Católica de Chile, Santiago

All Listed Sponsors
lead

Pontificia Universidad Catolica de Chile

OTHER

NCT03078712 - Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK Study | Biotech Hunter | Biotech Hunter